These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


141 related items for PubMed ID: 20106827

  • 1. Immunohistochemical expression of pituitary tumor transforming gene (PTTG) in pituitary adenomas: a correlative study of tumor subtypes.
    Salehi F, Kovacs K, Scheithauer BW, Cantelmi D, Horvath E, Lloyd RV, Cusimano M.
    Int J Surg Pathol; 2010 Feb; 18(1):5-13. PubMed ID: 20106827
    [Abstract] [Full Text] [Related]

  • 2. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
    Teramoto A, Sanno N, Tahara S, Osamura YR.
    Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
    [Abstract] [Full Text] [Related]

  • 3. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
    Sánchez-Tejada L, Sánchez-Ortiga R, Moreno-Pérez O, Montañana CF, Niveiro M, Tritos NA, Alfonso AM.
    Endocrinol Nutr; 2013 Aug; 60(7):358-67. PubMed ID: 23416216
    [Abstract] [Full Text] [Related]

  • 4. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.
    Cristina C, Díaz-Torga GS, Goya RG, Kakar SS, Perez-Millán MI, Passos VQ, Giannella-Neto D, Bronstein MD, Becu-Villalobos D.
    Mol Cancer; 2007 Jan 12; 6():4. PubMed ID: 17222350
    [Abstract] [Full Text] [Related]

  • 5. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.
    Vidal S, Kovacs K, Horvath E, Rotondo F, Kuroki T, Lloyd RV, Scheithauer BW.
    Mod Pathol; 2002 Nov 12; 15(11):1205-12. PubMed ID: 12429800
    [Abstract] [Full Text] [Related]

  • 6. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.
    Filippella M, Galland F, Kujas M, Young J, Faggiano A, Lombardi G, Colao A, Meduri G, Chanson P.
    Clin Endocrinol (Oxf); 2006 Oct 12; 65(4):536-43. PubMed ID: 16984249
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical expression of SNAP-25 protein in adenomas of the human pituitary.
    Rotondo F, Kovacs K, Scheithauer BW, Horvath E, Bell CD, Lloyd RV, Cusimano M.
    Appl Immunohistochem Mol Morphol; 2008 Oct 12; 16(5):477-81. PubMed ID: 18633321
    [Abstract] [Full Text] [Related]

  • 8. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
    Brito J, Sáez L, Lemp M, Liberman C, Michelsen H, Araya AV.
    Rev Med Chil; 2008 Jul 12; 136(7):831-6. PubMed ID: 18949157
    [Abstract] [Full Text] [Related]

  • 9. Transcripts of PTTG and growth factors bFGF and IGF-1 are correlated in pituitary adenomas.
    Chamaon K, Kanakis D, Mawrin C, Dietzmann K, Kirches E.
    Exp Clin Endocrinol Diabetes; 2010 Feb 12; 118(2):121-6. PubMed ID: 19472104
    [Abstract] [Full Text] [Related]

  • 10. [Expression of pituitary tumor transforming gene, endostatin, and basic fibroblast growth factor mRNAs in invasive pituitary adenomas].
    Chen L, Liu YS, Wang LS, Yin HG, Hou QT, Liu ZX, Chen LH, Ling F.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec 12; 29(6):651-3, 666. PubMed ID: 16114549
    [Abstract] [Full Text] [Related]

  • 11. Effects of somatostatin-14 and the receptor-specific somatostatin analogs on chromogranin A and alpha-subunit (alpha-SU) release from "clinically nonfunctioning" pituitary adenoma cells incubated in vitro.
    Pawlikowski M, Lawnicka H, Pisarek H, Kunert-Radek J, Radek M, Culler MD.
    J Physiol Pharmacol; 2007 Mar 12; 58(1):179-88. PubMed ID: 17440235
    [Abstract] [Full Text] [Related]

  • 12. Estrogen receptors alpha and beta immunohistochemical expression: clinicopathological correlations in pituitary adenomas.
    Manoranjan B, Salehi F, Scheithauer BW, Rotondo F, Kovacs K, Cusimano MD.
    Anticancer Res; 2010 Jul 12; 30(7):2897-904. PubMed ID: 20683030
    [Abstract] [Full Text] [Related]

  • 13. The expression of ghrelin in somatotroph and other types of pituitary adenomas.
    Wasko R, Jaskula M, Kotwicka M, Andrusiewicz M, Jankowska A, Liebert W, Sowinski J.
    Neuro Endocrinol Lett; 2008 Dec 12; 29(6):929-38. PubMed ID: 19112387
    [Abstract] [Full Text] [Related]

  • 14. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas.
    Zhang X, Horwitz GA, Heaney AP, Nakashima M, Prezant TR, Bronstein MD, Melmed S.
    J Clin Endocrinol Metab; 1999 Feb 12; 84(2):761-7. PubMed ID: 10022450
    [Abstract] [Full Text] [Related]

  • 15. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis.
    Heaney AP, Horwitz GA, Wang Z, Singson R, Melmed S.
    Nat Med; 1999 Nov 12; 5(11):1317-21. PubMed ID: 10546001
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical analysis of GH-producing adenomas--with special emphasis on plurihormonality of individual tumor cells by double staining.
    Inada K, Oda K, Utsunomiya H, Itoh J, Osamura RY.
    Tokai J Exp Clin Med; 1992 Dec 12; 17(5-6):213-22. PubMed ID: 1285309
    [Abstract] [Full Text] [Related]

  • 17. The relationship between pituitary tumour transforming gene (PTTG) expression and in vitro hormone and vascular endothelial growth factor (VEGF) secretion from human pituitary adenomas.
    Hunter JA, Skelly RH, Aylwin SJ, Geddes JF, Evanson J, Besser GM, Monson JP, Burrin JM.
    Eur J Endocrinol; 2003 Feb 12; 148(2):203-11. PubMed ID: 12590639
    [Abstract] [Full Text] [Related]

  • 18. Pathobiology of pituitary adenomas and carcinomas.
    Scheithauer BW, Gaffey TA, Lloyd RV, Sebo TJ, Kovacs KT, Horvath E, Yapicier O, Young WF, Meyer FB, Kuroki T, Riehle DL, Laws ER.
    Neurosurgery; 2006 Aug 12; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
    [Abstract] [Full Text] [Related]

  • 19. Genetic abnormalities of somatostatin receptors in pituitary tumors.
    Lania A, Mantovani G, Spada A.
    Mol Cell Endocrinol; 2008 May 14; 286(1-2):180-6. PubMed ID: 17913341
    [Abstract] [Full Text] [Related]

  • 20. Conventional examination versus immunohistochemistry in the prediction of hormone profile of pituitary adenomas. An analysis on 142 cases.
    Bălinişteanu B, Ceauşu RA, Cîmpean AM, Baciu I, Băculescu N, Coculescu M, Raica M.
    Rom J Morphol Embryol; 2011 May 14; 52(3 Suppl):1041-5. PubMed ID: 22119822
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.